Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Public ClinicalTrials.gov record NCT03397394. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-label Study of Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the ATLAS study is to determine how patients with locally advanced unresectable or metastatic urothelial carcinoma respond to treatment with rucaparib.
Study identification
- NCT ID
- NCT03397394
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 97 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 1, 2018 (Actual)
- Primary completion
- Dec 12, 2019 (Actual)
- Completion
- Jan 15, 2020 (Actual)
- Last update posted
- Jun 9, 2023
2018 – 2020
United States locations
- U.S. sites
- 41
- U.S. states
- 28
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pinnacle Oncology, Honor Health | Scottsdale | Arizona | 85258 | — |
| University of California San Diego (UCSD), Moores Cancer Center | La Jolla | California | 92093 | — |
| University of California, Los Angeles (UCLA) | Los Angeles | California | 90095 | — |
| Universityof California, Irvine | Orange | California | 92868 | — |
| Saint John's Health Center - John Wayne Cancer Institute (JWCI) | Santa Monica | California | 90404 | — |
| Stanford University School of Medicine | Stanford | California | 94304 | — |
| Hartford Health Care Cancer Institute | Hartford | Connecticut | 06102 | — |
| Eastern Connecticut Hematology & Oncology Associates (ECHO) | Norwich | Connecticut | 06360 | — |
| Medstar Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Miami Cancer Institute, Baptist Health South Florida | Miami | Florida | 33176 | — |
| Northwestern University, Chicago | Chicago | Illinois | 60611 | — |
| Indiana University - Melvin and Bren Simon Cancer Center (IUSCC) | Indianapolis | Indiana | 46202 | — |
| The University of Iowa and Holden Comprehensive Cancer Center | Iowa City | Iowa | 52242 | — |
| Norton Cancer Center | Louisville | Kentucky | 40207 | — |
| Ochsner Cancer Institute | New Orleans | Louisiana | 70121 | — |
| University of Maryland, Marlene and Stewart Greenebaum Cancer Center | Baltimore | Maryland | 21201 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Minnesota Oncology Hematology P.A. (USO - US Oncology) | Minneapolis | Minnesota | 55404 | — |
| Comprehensive Cancer Centers of Nevada (CCCN) | Las Vegas | Nevada | 89169 | — |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| University of New Mexico UNM Cancer Research and Treatment Center | Albuquerque | New Mexico | 87102 | — |
| New York Oncology Hematology, P.C. (USO - US Oncology) | Albany | New York | 12208 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| New York - Presbyterian Hospital-Weill Cornell Medical Center | New York | New York | 10021 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Duke University, Duke Cancer Institute | Durham | North Carolina | 27710 | — |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| Northwest Cancer Specialists P.C. (USO - US Oncology) | Portland | Oregon | 97062 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18103 | — |
| Penn State Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Atlantic Urology Clinics | Myrtle Beach | South Carolina | 29572 | — |
| University Oncology & Hematology | Chattanooga | Tennessee | 37403 | — |
| Urology Associates | Nashville | Tennessee | 37209 | — |
| Texas Oncology PA (USO - US Oncology) | Dallas | Texas | 76201 | — |
| University of Texas, UT Health Science Center | Houston | Texas | 77030 | — |
| University of Utah, Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| University of Virginia, Emily Couric Clinical Center | Charlottesville | Virginia | 22908 | — |
| University of Washington / Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
| Froedtert & Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03397394, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03397394 live on ClinicalTrials.gov.